Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1047 USD | -5.86% | -23.69% | -48.68% |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock
- Equities
- Stock NovaBay Pharmaceuticals - Nyse
- News NovaBay Pharmaceuticals
- NovaBay Pharmaceuticals : Ladenburg Thalmann Adjusts NovaBay Pharmaceuticals PT to $2.20 From $1.90, Maintains Buy Rating